Table 2 Outcomes according to antifungal regimen in adults and children with confirmed mucormycosis (n = 164).
LAMB† | LAMB and posaconazole | LAMB with other triazoles | LAMB with azole and caspofungin | |||||
|---|---|---|---|---|---|---|---|---|
Survival | Mortality | Survival | Mortality | Survival | Mortality | Survival | Mortality | |
Children | 35 (92.1%) | – | 3 (7.9%) | – | – | – | – | – |
Adults | 87 (69.0%) | 16 (12.6%) | 2 (1.6%) | 2 (1.9%) | 5 (4.0%) | 4 (3.1%) | 4 (3.1%) | 2 (1.6%) |
p value | < 0.001 | 0.28 | – | – | ||||
